Sclerotherapy for leg varicose veins - Institute of Health Economics
Sclerotherapy for leg varicose veins - Institute of Health Economics
Sclerotherapy for leg varicose veins - Institute of Health Economics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Sclerotherapy</strong> <strong>for</strong> <strong>leg</strong> <strong>varicose</strong> <strong>veins</strong><br />
secondary changes due to previous venous thrombosis. These causes can lead to reflux,<br />
obstruction or both. Consequently <strong>varicose</strong> <strong>veins</strong> tend to be both chronic and recurrent.<br />
Most <strong>varicose</strong> <strong>veins</strong> are manifestations <strong>of</strong> primary venous insufficiency.<br />
The prevalence <strong>of</strong> <strong>varicose</strong> <strong>veins</strong> is estimated to be between 2% and 40%<br />
25. Although prevalence and incidence <strong>of</strong> <strong>varicose</strong> <strong>veins</strong> increase with age in both<br />
genders, they appear to be more common in women than in men. Risk factors include<br />
genetic predisposition, hormonal changes and pregnancy, obesity, lifestyle, venous<br />
thrombosis, <strong>leg</strong> injury, and prolonged standing 3, 5, 6, 7, 18, 19, 21-24 .<br />
2, 3, 5, 7, 8, 9-14, 16, 18-<br />
Varicose <strong>veins</strong> can be asymptomatic, produce aesthetic damage and/or discom<strong>for</strong>t or<br />
be responsible <strong>for</strong> functional and/or objective signs and symptoms <strong>of</strong> CVI (Expert<br />
review, Document-reply #1) 2, 3, 6, 7, 8, 9-14, 16, 18-27 . Commonly reported symptoms include<br />
local discom<strong>for</strong>t (aching, pain, itchiness, and burning sensation), generalized lower <strong>leg</strong><br />
symptoms (<strong>leg</strong>-tiredness, restless <strong>leg</strong> syndrome, heaviness, skin changes and<br />
swelling/edema) and cramps.<br />
Differentiation between symptomatic and asymptomatic <strong>varicose</strong> <strong>veins</strong> remains a<br />
challenge. The symptoms are not clearly defined and not always related to the degree<br />
or size <strong>of</strong> the <strong>varicose</strong> <strong>veins</strong> (Expert review, Document-reply #1) 2, 4, 27 . There is evidence to<br />
suggest that the severity <strong>of</strong> discom<strong>for</strong>t produced by <strong>varicose</strong> <strong>veins</strong> is disproportionate<br />
to the amount <strong>of</strong> the pathologic change present (Document-reply #1, Appendix D).<br />
Varicose <strong>veins</strong> slowly progress with enlargement and distal extension and, if untreated,<br />
may eventually lead to severe complications such as bleeding, thrombophlebitis, and<br />
<strong>leg</strong> ulcer (venous ulceration) (Expert review, Document-reply #1) (Dunn, personal<br />
communication) 2, 7, 8, 12, 16, 18, 21-24, 28 . Varicose <strong>veins</strong> (particularly small ones) do not<br />
usually cause severe complications even if they are present over very long periods <strong>of</strong><br />
time (Dunn, personal communication) 8, 14, 15, 23, 24 . Some evidence suggests that about 50%<br />
<strong>of</strong> patients with significant superficial venous insufficiency if left untreated will<br />
eventually suffer from CVI with severe complications 29 . However, the exact incidence<br />
<strong>of</strong> significant symptoms or severe complications in these patients has not been clearly<br />
determined yet (Soriano, personal communication) 4 .<br />
Treatment<br />
The actual cause <strong>of</strong> <strong>varicose</strong> <strong>veins</strong> <strong>of</strong> the <strong>leg</strong>s remains unclear and there is no known<br />
cure 2, 7, 10, 14, 19-23, 30, 31 . Treatment is palliative and aims to relieve symptoms, prevent<br />
and/or manage potentially disabling complications, and improve cosmetic appearance.<br />
Asymptomatic <strong>varicose</strong> <strong>veins</strong> may be considered <strong>for</strong> treatment to improve cosmetic<br />
appearance (Dunn, personal communication) 3, 4, 14, 19, 22, 23 . Treatment <strong>for</strong> telangiectasia<br />
and reticular varicosities is most commonly per<strong>for</strong>med <strong>for</strong> cosmetic concerns and may<br />
not be considered medically necessary 3, 14, 15, 19, 20, 23, 24, 26, 30, 32-35 . Although most <strong>of</strong> the<br />
Alberta Heritage Foundation <strong>for</strong> Medical Research<br />
<strong>Health</strong> Technology Assessment<br />
3